Latest News
January 13, 2015
Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital
September 17, 2014
Debiopharm Diagnostics portfolio company Biocartis ships its first Idylla instrument
January 8, 2014
Spinomix announces a milestone payment from Debiopharm Group™ and the appointment of a new CEO
June 19, 2012
Debiopharm, Immunexpress and Biocartis Announce Collaboration to Advance Development of SeptiCyte® Triage for Managing Sepsis
April 8, 2010
Debiopharm Group™ and Biocartis embark on a partnership aiming at enhancing personalized medicine